Fig. 7From: How to design a dose-finding study using the continual reassessment methodResults from the dose-finding trial of rViscumin in patients with solid tumours [65]a) Trial conduct and DLTs observed. b) Final mean estimates of DLT probabilities and 95% confidence intervals.Back to article page